BRIEF-Cipher Pharmaceuticals Q2 loss per share c$0.13

Wed Aug 10, 2016 7:19am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Aug 10 (Reuters) - Cipher Pharmaceuticals Inc

* Cipher pharmaceuticals reports q2 2016 results highlighted by 32% revenue growth and $3.1 million cash from operations

* Cipher pharmaceuticals inc qtrly total revenue of $11.7 million, an increase of 32% from $8.8 million in q2 2015

* Q2 loss per share c$0.13 Source text for Eikon: Further company coverage: